“Low Dose Naltrexone (LDN) is a drug that is credited with helping those with HIV/AIDS, cancer, autoimmune diseases, and central nervous system disorders (including MS) by boosting (modulating) the immune system. As well as being effective it is cheap, costing less than one pound a day, and could save the NHS vast sums of money.
We therefore urge the Govenment to fund a trial of LDN on the NHS so that everyone in the UK can reap the benefits of this drug.” Stephen Crabb MP
IMPORTANT NEWS:: The inaugural meeting of the All Party Parliamentary Group on Low Dose Naltrexone (LDN) will take place on
Thursday, 13th September 2012, at 10.30 am
